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Abstract. Serological studies on a patient whose red cells are polyagglutinable 
due to T activation have demonstrated concomitant T activity of the separated 
leukocytes and platelets. Normal leukocytes and platelets are not T active, but 
activation can be induced in vitro by treatment with neuraminidase or with pneumo- 
coccus type I11 filtrate. Such T-active cells absorb anti-T from Arachis hypogea 
lectin. Tests on different types of separated leukocytes show that both neutrophils 
and lymphocytes have latent T antigen receptors. Neuraminidase treatment of 
platelets does not change their ability to promote clot retraction, to aggregate with 
ADP, or to take up serotonin. 
There is evidence that apart from the ABO blood group system [2, 
6, 171, a number of antigenic determinants are common to different types 
of hemopoietic cells. I and i antigens are present on leukocytes [8 ] ,  the 
5b leukocyte antigen is present on red cells [14], and recent investiga- 
tions have demonstrated that the anti-erythrocyte antibodies, anti-Kx 
[12], anti-U [lo] and anti-Gerbich [ll] can be absorbed by neutrophil 
leukocytes and monocytes from individuals of appropriate genotype. 
Within each of these last three blood-group systems other antibodies 
defining red-cell polymorphisms are not absorbed by leukocytes. Normal 
red cells, leukocytes, and platelets have also been reported to possess 
latent T antigen receptors. In vitro studies have shown that incubation of 
these cells with neuraminidase induces the ability to absorb anti-T from 
Aruchis hypogeu lectin [7]. 
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This report presents studies which demonstrate that in vivo T activa- 
tion of leukocytes and platelets occurs concomitantly with T activation 
of erythrocytes. Investigation of separated neutrophils, Iymphocytes, and 
platelets has confirmed their susceptibility to in vitro T activation and 
established that such change does not significantly impair the ability of 
platelets to promote clot retraction or to aggregate with ADP. 
Materials and Metliods 
In  vivo T Activation 
Approximately 100ml of blood was collected into heparin lrom a group AB 
patient with hemolytic anemia secondary to subhepatic abscess, in whom the red 
cells were T active. Proteus mirabiiis, Klebsiella pneunioniae, and Clostridium 
perfringens were cultured from the abscess at the time of operative drainage. The 
patient's red cells were agglutinated by A .  Iiypogcn lectin, which contains anti-T 
[3]; but not by Salvia sclarea lectin which has anti-Tn specificity, or by Salviu 
liorniimum lectin which has both anti-Tn and anti-Cad activity [4]. The heparinized 
blood was centrifuged at  200 g for 15 min at 4 O C  and the supernatant plasma con- 
taining the platelets removed. The buffy coat was also removed and after resuspen- 
sion in a small volume of the plasma was recentrifuged using the same param- 
eters. The buffy coat was sucpended in Hanks' solution, and anti-A,B serum that 
had been processed to remove anti-T, was used to agglutinate and sediment the 
remaining erythrocytes. The leukocyte and platelet suspensions were combined 
since the volume of each fraction was small. Leukocytes and platelets wcre 
prepared from blood of a healthy donor by a similar technique. The leukocyte 
platelet preparations from the patient and the control were each incubated with 
Arucizis lectin at 4 OC for 60 min. The cells were washed four times with saline and 
an ether eluate prepared [15]. The eluate and, as a control, the supernatant fluid 
from the final sa!ine wash were tested for activity against the polyagglutinable red 
cells of the patient as well as neuraminidase-treated and untreated red cells. 
I n  vitro T Activation 
Buffy coats from 6 U  of centrifuged group 0 donor blood collected into acid- 
citrate-dextrose solution were separated, pooled, and contaminating red cells in the 
mixture were eliminated by the addition of dextran. The leukocyte-platelet suspen- 
sion obtained was separated into its cellular components by centrifugation in a 
hypaque-dextran discontinuous gradient 1161. This technique yields three fractions 
containing predominantly neutrophils, lymphocytes, and platelets, respectively. The 
cell fractions were separated and washed, and an aliquot of the washed donor red 
cells was taken as a fourth fraction. Each of the four cell fractions was divided into 
three equal volumes. One volume was incubated with 4 vol of 0.05% papain solution 
at 37 O C  for 15 min and the enzyme subsequently removed by washing. The second 
portion of each cell fraction was incubated with an equal amount of a known T- 
activating pneumococcal (type 111) filtrate for 30 min at 37 OC, and the cells washed. 
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The third portion of each cell fraction was kept as an untreated control. Each of 
the resulting 12-cell suspensions was packed by centrifugation and used to absorb an 
equal volume of Arachis lectin at 1 2 O C  for 60min. Anti-T activity was assessed 
by titration against T-active group 0 red cells and compared with the score obtained 
following absorption with untreated erythrocytes. These experiments were repeated 
on a second series of six buffy coat cell preparations to establish the reproducibility 
of the results. A third series of six buffy coat preparations from group 0, D-positive 
donors were used to absorb anti-D instead of Aruchis lectin, to confirm that uptake 
of anti-T by neuraminidase-treated leukocytes and platelets is a specific phenome- 
non, and to ensure that the leukocyte-platelet preparations were free of contaminat- 
ing red cells or red cell stroma. 
In a further study, leukocyte preparations were prepared from the blood of 
four donors, and pooled. Lymphocytes were isolated by hypaque-dextran dis- 
continuous gradient centrifugation and the separated cells divided into two aliquots. 
One was incubated with neuraminidase at a concentration of 50U/ml for 30min 
at 37OC, washed, and checked for T activity by using some of the cells in an 
absorption-elution test with Aruchis lectin. The second part of the lymphocyte 
preparation was left untreated and used in a parallel Aruchis absorption experiment 
as a control. 
Platelet Function Tests 
Blood of ten nonfasting donors who, as far as could be ascertained, had taken 
no medication in the previous 7 days, was collected into acid-citrate-dextrose solu- 
tion. The platelets were separated by differential centrifugation in a hypaque-dextran 
gradient and pooled. After washing in buffered saline, the cell suspension was 
divided into two aliquots. One was retained as an untreated control, while the 
other was incubated with neuramicidase at a concentration of 50 U/ml for 30 min 
at 37 OC. Enzyme treatment was arrested by further washing and a portion of the 
cells checked for T activation by an absorption-elution test with Aruchis lectin. 
Platelet 14C-serotonin uptake and release of the enzyme-treated and control 
cells was investigated by the method of ZUCKER and PETERSON [18]. The aggregative 
response of the platelets to added epinephrine and adenosine diphosphate was 
measured in a chronolog platelet aggregometer. To determine clot retracting 
capability, treated and untreated platelets were added to platelet-poor heterologous 
plasma to give a final concentration of 250,OOO/,ul. 5 U  of thrombin were added 
to 2-ml volumes of the test preparations and clot retraction measured by the 
method of BENTHAUS [l]. 
Results 
In vivo T Activation 
Microscopic examination of the patient’s leukocyte-platelet prepara- 
tion revealed many neutrophils, lymphocytes, monocytes, and platelets, 
as well as an occasional red cell. The proportion of red cells to leukocytes 
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Table I .  Reactivity of Arachis hypogea lectin recovered after absorption and elution 
using a leukocyte-platelet preparation (4 OC, 15 min) 
Source of leukocyte- 
platelet preparation 
Red cells used to test eluate 
control T-active patient 
untreated neuraminidase 






TabIe I I .  Titration scores [9] of Arachis hypogea Iectin after absorption with enzyme- 
treated or untreated separated cell fractions 
Absorbing cells Untreated Treatment of absorbing cells 









Table I I I .  Results of absorbing Arachis hypogea lectin with neuraminidase-treated 
and untreated lymphocytes 
Reciprocals of dilutions of Arachis lectin Score [9] 
2 4 8 16 32 64 128 
Before absorption 12 12 12 7 6 3 0 52 
After absorption with 
Untreatedlymphocytes 12 12 12 5 4 2 0 47 
Neuraminidase- 
treated lymphocytes 3 0 0 0 0 0 0  3 
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was determined by direct count. Based on this ratio, sufficient T-active 
red cells from the patient were added to the normal control preparation 
to give the same final proportion. The patient and control leukocyte- 
platelet preparations were then used in absorption-elution experiments 
with Arachis anti-T lectin. The results shown in table I, establish that the 
leukocyte-platelet preparation from the patient’s blood had strong ab- 
sorptive capacity for anti-T, while the control preparation had none. In 
both cases, efficiency of the final cell washing procedure was dem- 
onstrated by testing the last wash solution for anti-T activity. 
In vitro T Activation 
Microscopic examination of the separated cellular components of the 
buffy coat preparations revealed the platelet fraction and the neutrophil 
fraction to be essentially pure, and the lymphocyte fraction to contain 
predominantly lymphocytes with small numbers of monocytes. Following 
treatment of the neutrophil preparation with papain, the cells became 
difficult to separate and prolonged centrifugation was necessary. The 
results of absorbing Arachis lectin with aliquots of the different cell 
fractions that had been treated with papain, with T-activating pneumo- 
coccus filtrate, or left untreated, are shown in table 11. Absorption with 
papain-treated or untreated cells did not reduce the anti-T activity of 
the Arachis lectin. Absorption with platelet and both leukocyte pneumo- 
coccus filtrate-treated preparations caused a significant decrease in anti- 
T activity. None of the leukocyte or platelet preparations absorbed anti- 
D, thus confirming that these cell fractions were not contaminated with 
red cells. All of the red cell preparations absorbed anti-D and as expected 
the red cells exposed to papain or T-activating filtrate removed more 
antibody than the untreated cells. Neuraminidase-treated normal lympho- 
cytes showed strong absorptive capacity for lectin anti-T but untreated 
cells had no such capability (table 111). 
Platelet Function Tests 
Both neuraminidase-treated and untreated platelets showed normal 
uptake of 14C-serotonin, but in neither case was it released by the addi- 
tion of adenosine diphosphate (ADP) or epinephrine. Both platelet 
preparations gave the same low normal results in tests for aggregation 
following addition of ADP. Neuraminidase treatment did not affect 
ability of the platelets to induce clot retraction and both cell preparations 
gave the same normal result. 
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Discussion 
In vivo polyagglutinability caused by T activation has long been re- 
cognized as an enzymatically induced modification of red cells. It is, how- 
ever, apparent that the plienornenon is in reality one of more genera!ized 
desialization that exposes latent antigen receptors in red cells, leuko- 
cytes, and platelets. It appears that the terminal neuraminyl groups 
which are characteristic of vertebrate blood and tissue cells [13] are 
attached to a common fundamental membrane structure, which, following 
cleavage of neuraminyl groups by neuraminidase, interacts specifically 
with anti-T of Arachis lectin. 
Tn receptors have also been demonstrated on all cellular hemopoietic 
elements [7] .  While patients whose red cells are polyagglutinable due to 
Tn activation frequently exhibit leukopenia and thrombocytopenia [ 5 ] ,  
similar changes are not typical of in vivo polyagglutination caused by 
T activation. Furthermore, while the technical procedures used in isolat- 
ing platelets for in vitro T activation impaired their functional activity 
in some of the studies, the T-active platelets showed no more deficiency 
than did the untreated control platelets. I: appears possible, therefore, 
that the generalized hematologic in vivo antigenic changes that are seen 
in T activation may not affect cell functional activities. 
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